Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
顾勇 et al., 2000 - Google Patents
[go: Go Back, main page]

顾勇 et al., 2000 - Google Patents

Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients

顾勇 et al., 2000

Document ID
14604298747975204841
Author
顾勇
丁峰
秦慧莲
赵涵芳
林善锬
Publication year
Publication venue
中华医学杂志: 英文版

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system

Similar Documents

Publication Publication Date Title
Takatsu et al. IL-5 and eosinophilia
Luger et al. Blood–membrane interaction in hemodialysis leads to increased cytokine production
Lee et al. Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management
Bingel et al. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes
Granowitz et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans.
Kuhns et al. Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections
Memoli et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells
Goodacre et al. Morphologic and functional characteristics of human intestinal lymphoid cells isolated by a mechanical technique
Kimmel et al. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease
Tekstra et al. Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients.
Kanegane et al. Severe neutropenia in Japanese patients with x-linked agammaglobulinemia
Grooteman et al. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes.
Tsuzuki et al. Functional interleukin‐33 receptors are expressed in early progenitor stages of allergy‐related granulocytes
Donati et al. Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis model.
Bourantas et al. Serum beta‐2‐microglobulin, TNF‐α and interleukins in myeloproliferative disorders
Burke et al. Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte macrophage colony-stimulating factor (GM-CSF)
Fireman et al. Sarcoidosis: an organized pattern of reaction from immunology to therapy
顾勇 et al. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients
Cerasoli Jr et al. Superoxide anion release from blood and bone marrow neutrophils is altered by endotoxemia.
Vincent et al. Inhibitor of in-vitro granulopoiesis in plasma of patients with renal failure
Pereira et al. Comparison of First Use and Reuse of Cuprophan Membranes on Interleukin-1 Receptor Antagonist and Interleukin-1β Production by Blood Mononuclear Cells
Toft et al. Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL‐8 and IL‐10
Carney et al. Cell-mediated immune defects and infection: A study of malnourished hospitalized children
Donati et al. Interleukin-1 receptors and receptor antagonist in haemodialysis
Vaziri et al. Induction, transcription, synthesis, and adsorption of interleukin-1 by dialyzer membranes.